Septerna, Inc.
SEPN
$6.51
-$0.23-3.41%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/12/2025
-
Insider Monkey
3/11/2025
-
GuruFocus
3/11/2025
-
PR Newswire
3/8/2025
-
MarketBeat
3/8/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/7/2025
-
GuruFocus
3/5/2025
-
Insider Monkey
3/3/2025
-
GuruFocus
3/3/2025
-
PR Newswire
3/1/2025
-
MarketBeat
3/1/2025
-
MarketBeat
2/28/2025
-
MarketBeat
2/26/2025
-
GuruFocus
2/26/2025
-
Globe Newswire
2/25/2025
-
Market News Video
2/23/2025
-
MarketBeat
2/23/2025
-
MarketBeat
2/22/2025
-
MarketBeat
2/22/2025
-
MarketBeat
2/22/2025
-
GuruFocus
2/20/2025
-
MarketBeat
2/19/2025
-
GuruFocus
2/19/2025
-
MarketBeat
2/18/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, November 20, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Sep 8 and 12 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 338 3533
Address
250 East Grand Avenue
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology...
more
